| REXIBEL NOVARTIS AG
1638528 07 Aug 2013 | on 29 Aug 2016 | Class 005 Class 005 Pharmaceutical Products Vaccines for human use. | | | REXIBEL NOVARTIS AG
1290939 22 Feb 2006 | on 11 Sep 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases including metabolic disorders and diabetes; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; immunosuppressants; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in ocular disorders; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use. | |